Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis

ClinicalTrials.gov ID: NCT01216072

Public ClinicalTrials.gov record NCT01216072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-month, Randomized, Active Comparator, Open-label, Multi-Center Study to Evaluate Patient OutComes, Safety and Tolerability of Fingolimod (FTY720) 0.5 mg/Day in Patients With Relapsing Forms of Multiple Sclerosis Who Are Candidates for MS Therapy Change From Previous Disease Modifying Therapy (EPOC)

Study identification

NCT ID
NCT01216072
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,053 participants

Conditions and interventions

Interventions

  • Fingolimod Drug
  • Standard MS DMTs Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Jul 31, 2012
Completion
Jul 31, 2012
Last update posted
Feb 9, 2014

2010 – 2012

United States locations

U.S. sites
142
U.S. states
34
U.S. cities
128
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35209
Novartis Investigative Site Cullman Alabama 35058
Novartis Investigative Site Phoenix Arizona 85004
Novartis Investigative Site Phoenix Arizona 85006
Novartis Investigative Site Phoenix Arizona 85013
Novartis Investigative Site Phoenix Arizona 85032
Novartis Investigative Site Tucson Arizona 85741
Novartis Investigative Site Anaheim California 92801
Novartis Investigative Site Berkeley California 94705
Novartis Investigative Site Fresno California 93710
Novartis Investigative Site Fullerton California 92835
Novartis Investigative Site La Habra California 90631
Novartis Investigative Site Loma Linda California 92354
Novartis Investigative Site Newport Beach California 92660
Novartis Investigative Site Oceanside California 92056
Novartis Investigative Site Sacramento California 95817
Novartis Investigative Site Walnut Creek California 94598
Novartis Investigative Site Boulder Colorado 80304
Novartis Investigative Site Colorado Springs Colorado 80920
Novartis Investigative Site Fort Collins Colorado 80528
Novartis Investigative Site Fairfield Connecticut 06824
Novartis Investigative Site New London Connecticut 06320
Novartis Investigative Site Stratford Connecticut 06615
Novartis Investigative Site Dover Delaware 19901
Novartis Investigative Site Newark Delaware 19713
Novartis Investigative Site Atlantis Florida 33462-6608
Novartis Investigative Site Bradenton Florida 32405
Novartis Investigative Site Doral Florida 33166
Novartis Investigative Site Fort Lauderdale Florida 33308
Novartis Investigative Site Hollywood Florida 33021
Novartis Investigative Site Jacksonville Florida 32209
Novartis Investigative Site Jacksonville Florida 32216
Novartis Investigative Site Lighthouse PT Florida 33064
Novartis Investigative Site Maitland Florida 32751
Novartis Investigative Site Miami Florida 33015
Novartis Investigative Site Miami Florida 33133
Novartis Investigative Site Pompano Beach Florida 33060
Novartis Investigative Site Ponte Vedra Beach Florida 32082-4627
Novartis Investigative Site Port Orange Florida 32127
Novartis Investigative Site Sarasota Florida 34243
Novartis Investigative Site St. Petersburg Florida 33713
Novartis Investigative Site Sunrise Florida 33351
Novartis Investigative Site Tallahassee Florida 32308
Novartis Investigative Site Tampa Florida 33609
Novartis Investigative Site Tampa Florida 33612
Novartis Investigative Site Vero Beach Florida 32960
Novartis Investigative Site West Palm Beach Florida 33407
Novartis Investigative Site Atlanta Georgia 30302
Novartis Investigative Site Atlanta Georgia 30309
Novartis Investigative Site Columbus Georgia 31901
Novartis Investigative Site Decatur Georgia 30083
Novartis Investigative Site Idaho Falls Idaho 83402
Novartis Investigative Site Elk Grove Village Illinois 60007
Novartis Investigative Site Evanston Illinois 60201
Novartis Investigative Site Flossmoor Illinois 60422
Novartis Investigative Site Northbrook Illinois 60062
Novartis Investigative Site Anderson Indiana 46011
Novartis Investigative Site Indianapolis Indiana 46202-5111
Novartis Investigative Site Indianapolis Indiana 46256
Novartis Investigative Site Merrillville Indiana 46410
Novartis Investigative Site Valparaiso Indiana 46383
Novartis Investigative Site Des Moines Iowa 50314-2611
Novartis Investigative Site Lenexa Kansas 66214
Novartis Investigative Site Baton Rouge Louisiana 70809
Novartis Investigative Site Destrehan Louisiana 70047
Novartis Investigative Site Hammond Louisiana 70403
Novartis Investigative Site Metairie Louisiana 70001
Novartis Investigative Site Shreveport Louisiana 71101
Novartis Investigative Site Shreveport Louisiana 71130
Novartis Investigative Site Baltimore Maryland 21201
Novartis Investigative Site Bethesda Maryland 20814
Novartis Investigative Site Boston Massachusetts 02135
Novartis Investigative Site Springfield Massachusetts 01104
Novartis Investigative Site Worcester Massachusetts 01608
Novartis Investigative Site Worcester Massachusetts 01665
Novartis Investigative Site Detroit Michigan 48201
Novartis Investigative Site Grand Rapids Michigan 49503
Novartis Investigative Site Kalamazoo Michigan 49007
Novartis Investigative Site Southfield Michigan 48034
Novartis Investigative Site Bolivar Missouri 65613
Novartis Investigative Site Kansas City Missouri 64111
Novartis Investigative Site Kansas City Missouri 64132
Novartis Investigative Site Nixa Missouri 65714-7807
Novartis Investigative Site North Kansas City Missouri 64116
Novartis Investigative Site St Louis Missouri 63104
Novartis Investigative Site Billings Montana 59102
Novartis Investigative Site Freehold New Jersey 07728
Novartis Investigative Site Somerset New Jersey 08873
Novartis Investigative Site Teaneck New Jersey 07666
Novartis Investigative Site Toms River New Jersey 08755
Novartis Investigative Site Amherst New York 14226
Novartis Investigative Site Latham New York 12110
Novartis Investigative Site New York New York 10023
Novartis Investigative Site Patchogue New York 11772
Novartis Investigative Site Plainview New York 11803
Novartis Investigative Site Asheville North Carolina 28806
Novartis Investigative Site Burlington North Carolina 27215
Novartis Investigative Site Charlotte North Carolina 28204
Novartis Investigative Site Charlotte North Carolina 28207
Novartis Investigative Site Greensboro North Carolina 27401
Novartis Investigative Site Greenville North Carolina 27834
Novartis Investigative Site Raleigh North Carolina 27607
Novartis Investigative Site Salisbury North Carolina 28144
Novartis Investigative Site Wilmington North Carolina 28401
Novartis Investigative Site Winston-Salem North Carolina 27103
Novartis Investigative Site Akron Ohio 44320
Novartis Investigative Site Bellevue Ohio 44811
Novartis Investigative Site Canton Ohio 44718
Novartis Investigative Site Cincinnati Ohio 45219
Novartis Investigative Site Columbus Ohio 43221
Novartis Investigative Site Uniontown Ohio 44685
Novartis Investigative Site Oklahoma City Oklahoma 73112
Novartis Investigative Site Corvallis Oregon 97330
Novartis Investigative Site Eugene Oregon 97401
Novartis Investigative Site Medford Oregon 97504
Novartis Investigative Site Portland Oregon 97223
Novartis Investigative Site Monroeville Pennsylvania 15146
Novartis Investigative Site Rumford Rhode Island 02916
Novartis Investigative Site Beufort South Carolina 29902
Novartis Investigative Site Columbia Tennessee 38401
Novartis Investigative Site Cordova Tennessee 38018
Novartis Investigative Site Knoxville Tennessee 37934
Novartis Investigative Site Nashville Tennessee 37205
Novartis Investigative Site Austin Texas 78756
Novartis Investigative Site Colleyville Texas 76034
Novartis Investigative Site Dallas Texas 75204
Novartis Investigative Site Houston Texas 77025
Novartis Investigative Site Lubbock Texas 79410
Novartis Investigative Site Plano Texas 75075
Novartis Investigative Site Round Rock Texas 78681
Novartis Investigative Site San Antonio Texas 78229
Novartis Investigative Site San Antonio Texas 78258
Novartis Investigative Site Sherman Texas 75092
Novartis Investigative Site Salt Lake City Utah 84103
Novartis Investigative Site Newport News Virginia 23606
Novartis Investigative Site Richmond Virginia 23226
Novartis Investigative Site Roanoke Virginia 24014
Novartis Investigative Site Vienna Virginia 22182
Novartis Investigative Site Kirkland Washington 98034
Novartis Investigative Site Seattle Washington 98122
Novartis Investigative Site Seattle Washington 98144
Novartis Investigative Site Morgantown West Virginia 26506-9260

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01216072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01216072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →